Publication:
Myelodysplastic syndrome with pseudoreticulocytosis

dc.contributor.authorsÇetiner M., Kaygusuz I., Tecimer T., Ari E., Birtaş E., Noyan F., Adigüzel C., Firatli-Tuǧlular T., Bayik M.
dc.date.accessioned2022-03-28T14:53:01Z
dc.date.accessioned2026-01-11T14:08:49Z
dc.date.available2022-03-28T14:53:01Z
dc.date.issued2005
dc.description.abstractA patient with myelodysplastic syndrome (MDS) with refractory anemia who had marked reticulocytosis in the absence of hemolytic anemia and/or blood loss is reported. Erythrocyte survival test showed that more than 50% of the patient's reticulocytes were still present on day seven. This should be due to the prolongation of reticulocyte maturation in MDS, and is known as pseudoreticulocytosis. This phenomenon which mimicks hemolytic anemia is an unusual presentation of myelodysplastic syndrome, with only 7 patients with pseudoreticulocytosis being reported previously.
dc.identifier.issn13007777
dc.identifier.urihttps://hdl.handle.net/11424/255947
dc.language.isoeng
dc.relation.ispartofTurkish Journal of Haematology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMyelodysplastic syndrome
dc.subjectPseudoreticulocytosis
dc.titleMyelodysplastic syndrome with pseudoreticulocytosis
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage44
oaire.citation.issue1
oaire.citation.startPage41
oaire.citation.titleTurkish Journal of Haematology
oaire.citation.volume22

Files